-
2
-
-
0018191438
-
2+ precipitation procedures for estimating cholesterol in high-density lipoprotein
-
2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem. 24:1978;853-856.
-
(1978)
Clin Chem
, vol.24
, pp. 853-856
-
-
Albers, J.J.1
Warnick, G.R.2
Wiebe, D.3
-
3
-
-
0030022929
-
Clinical guideline, part 1. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults
-
The American College of Physicians
-
The American College of Physicians Clinical guideline, part 1. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 124:1996;515-517.
-
(1996)
Ann Intern Med
, vol.124
, pp. 515-517
-
-
-
4
-
-
0023121401
-
Cholesterol and mortality. Thirty years of follow-up from the Framingham Study
-
Anderson K.M., Castelli W.P., Levy D. Cholesterol and mortality. Thirty years of follow-up from the Framingham Study. JAMA. 257:1987;2176-2180.
-
(1987)
JAMA
, vol.257
, pp. 2176-2180
-
-
Anderson, K.M.1
Castelli, W.P.2
Levy, D.3
-
5
-
-
0028939363
-
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
-
Anderson T.J., Meredith I.T., Yeung A.C.et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
-
(1995)
N Engl J Med
, vol.332
, pp. 488-493
-
-
Anderson, T.J.1
Meredith, I.T.2
Yeung, A.C.3
-
6
-
-
0023807047
-
Low-density lipoprotein subclass patterns and risk of myocardial infarction
-
Austin M.A., Breslow J.L., Hennekens C.H.et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 260:1988;1917-1921.
-
(1988)
JAMA
, vol.260
, pp. 1917-1921
-
-
Austin, M.A.1
Breslow, J.L.2
Hennekens, C.H.3
-
7
-
-
0030587237
-
Lowering risk without lowering cholesterol. Implications for national cholesterol policy
-
Avins A.L., Browner W.S. Lowering risk without lowering cholesterol. Implications for national cholesterol policy. Ann Intern Med. 125:1996;502-506.
-
(1996)
Ann Intern Med
, vol.125
, pp. 502-506
-
-
Avins, A.L.1
Browner, W.S.2
-
8
-
-
0018107663
-
Relation between prognosis and the blood pressure before and during treatment of hypertensive patients
-
Beevers D.G., Johnston J., Devine B.L.et al. Relation between prognosis and the blood pressure before and during treatment of hypertensive patients. Clin Sci Mol Med. 4(Suppl):1978;333S-336S.
-
(1978)
Clin Sci Mol Med
, vol.4
, Issue.SUPPL
-
-
Beevers, D.G.1
Johnston, J.2
Devine, B.L.3
-
9
-
-
0029808302
-
Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene
-
Benlian P., DeGenes J.L., Foubert L.et al. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med. 335:1996;848-854.
-
(1996)
N Engl J Med
, vol.335
, pp. 848-854
-
-
Benlian, P.1
Degenes, J.L.2
Foubert, L.3
-
10
-
-
0017947456
-
Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia
-
Bilheimer D.W., Ho Y.K., Brown M.S.et al. Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia. J Clin Invest. 61:1978;678-696.
-
(1978)
J Clin Invest
, vol.61
, pp. 678-696
-
-
Bilheimer, D.W.1
Ho, Y.K.2
Brown, M.S.3
-
11
-
-
0026654987
-
Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures. Relationships to hepatic calcium metabolism
-
Björnsson ÓG., Sparks J.D., Sparks C.E., Gibbons G.F. Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures. Relationships to hepatic calcium metabolism. J Lipid Res. 33:1992;1017-1027.
-
(1992)
J Lipid Res
, vol.33
, pp. 1017-1027
-
-
Björnsson, Ó.G.1
Sparks, J.D.2
Sparks, C.E.3
Gibbons, G.F.4
-
12
-
-
0027455653
-
Dietary treatment and growth of hyperchylomicronemic children severely restricted in dietary fat
-
Black D.M., Sprecher D.L. Dietary treatment and growth of hyperchylomicronemic children severely restricted in dietary fat. Am J Dis Child. 147:1993;60-62.
-
(1993)
Am J Dis Child
, vol.147
, pp. 60-62
-
-
Black, D.M.1
Sprecher, D.L.2
-
13
-
-
0022549920
-
A receptor-mediated pathway for cholesterol homeostatis
-
Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostatis. Science. 232:1986;34-47.
-
(1986)
Science
, vol.232
, pp. 34-47
-
-
Brown, M.S.1
Goldstein, J.L.2
-
14
-
-
0030888615
-
Hypercholesterolemia in the United States. How far have we come?
-
Brown W.V. Hypercholesterolemia in the United States. How far have we come? Am J Med. 102:1997;3-6.
-
(1997)
Am J Med
, vol.102
, pp. 3-6
-
-
Brown, W.V.1
-
15
-
-
0015783897
-
Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man
-
Brunzell J.D., Hazzard W.R., Porte D., Bierman E.L. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 52:1973;1578-1585.
-
(1973)
J Clin Invest
, vol.52
, pp. 1578-1585
-
-
Brunzell, J.D.1
Hazzard, W.R.2
Porte, D.3
Bierman, E.L.4
-
16
-
-
0026609806
-
Decreased HDL2 and HDL3 cholesterol, apoA-I, and apoA-II, and increased risk for myocardial infarction
-
Buring J.E., O'Connor G.T., Goldhaber S.Z.et al. Decreased HDL2 and HDL3 cholesterol, apoA-I, and apoA-II, and increased risk for myocardial infarction. Circulation. 85:1992;22-29.
-
(1992)
Circulation
, vol.85
, pp. 22-29
-
-
Buring, J.E.1
O'Connor, G.T.2
Goldhaber, S.Z.3
-
17
-
-
85047691979
-
β-blockers, dyslipidemia, and coronary artery disease. A reassessment
-
Burris J.F. β-blockers, dyslipidemia, and coronary artery disease. A reassessment. Arch Intern Med. 153:1993;2085-2092.
-
(1993)
Arch Intern Med
, vol.153
, pp. 2085-2092
-
-
Burris, J.F.1
-
18
-
-
0028845911
-
Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program
-
Byington R.P., Jukema J.W., Salonen J.T.et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation. 92:1995;2419-2425.
-
(1995)
Circulation
, vol.92
, pp. 2419-2425
-
-
Byington, R.P.1
Jukema, J.W.2
Salonen, J.T.3
-
19
-
-
0023029454
-
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study
-
Castelli W.P., Garrisson R.J., Wilson P.W.F.et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 256:1986;2835-2838.
-
(1986)
JAMA
, vol.256
, pp. 2835-2838
-
-
Castelli, W.P.1
Garrisson, R.J.2
Wilson, P.W.F.3
-
20
-
-
0344084303
-
Role of lipids in predicting CHD risk
-
Castelli W.P. Role of lipids in predicting CHD risk. Choices Cardiol. 7:1993;128-131.
-
(1993)
Choices Cardiol
, vol.7
, pp. 128-131
-
-
Castelli, W.P.1
-
22
-
-
0026334459
-
Intestinally-derived lipoproteins. Metabolism and clinical significance
-
Chen Y.D.I., Reaven G.M. Intestinally-derived lipoproteins. Metabolism and clinical significance. Diabetes Metab Rev. 7:1991;191-208.
-
(1991)
Diabetes Metab Rev
, vol.7
, pp. 191-208
-
-
Chen, Y.D.I.1
Reaven, G.M.2
-
23
-
-
0030960979
-
Adults aged 20 and older should have their cholesterol measured
-
Cleeman J.I. Adults aged 20 and older should have their cholesterol measured. Am J Med. 102:1997;31-36.
-
(1997)
Am J Med
, vol.102
, pp. 31-36
-
-
Cleeman, J.I.1
-
24
-
-
0022959261
-
Prostaglandins and experimental hypertension. A review with special emphasis on the effect of dietary lipids
-
Codde J.P., Beilin L.J. Prostaglandins and experimental hypertension. A review with special emphasis on the effect of dietary lipids. J Hypertension. 4:1986;675-686.
-
(1986)
J Hypertension
, vol.4
, pp. 675-686
-
-
Codde, J.P.1
Beilin, L.J.2
-
25
-
-
0025124970
-
Topical timolol decreases plasma high-density lipoprotein cholesterol level
-
Coleman A.L., Diehl D.L.C., Jampel H.D.et al. Topical timolol decreases plasma high-density lipoprotein cholesterol level. Arch Ophthalmol. 108:1990;1260-1263.
-
(1990)
Arch Ophthalmol
, vol.108
, pp. 1260-1263
-
-
Coleman, A.L.1
Diehl, D.L.C.2
Jampel, H.D.3
-
26
-
-
0023895495
-
Use of an angiotensin-converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma
-
Constad W.H., Fiore P., Samson C., Cinotti A. Use of an angiotensin-converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol. 105:1988;674-677.
-
(1988)
Am J Ophthalmol
, vol.105
, pp. 674-677
-
-
Constad, W.H.1
Fiore, P.2
Samson, C.3
Cinotti, A.4
-
27
-
-
0023091633
-
Beta-blockers. Use for arrhythmias
-
Coumel P., Leclerq J.-F., Escoubet B. Beta-blockers. Use for arrhythmias. Eur Heart J. 8(Suppl A):1987;41-52.
-
(1987)
Eur Heart J
, vol.8
, Issue.SUPPL. A
, pp. 41-52
-
-
Coumel, P.1
Leclerq, J.-F.2
Escoubet, B.3
-
28
-
-
0026736537
-
The case for beta-blockers as first-line antihypertensive therapy
-
Cruickshank J.M. The case for beta-blockers as first-line antihypertensive therapy. J Hypertens. 10(Suppl 3):1992;S21-S27.
-
(1992)
J Hypertens
, vol.10
, Issue.SUPPL. 3
-
-
Cruickshank, J.M.1
-
30
-
-
0015922417
-
Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy
-
Davidoff F., Tishler S., Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med. 289:1973;552-555.
-
(1973)
N Engl J Med
, vol.289
, pp. 552-555
-
-
Davidoff, F.1
Tishler, S.2
Rosoff, C.3
-
31
-
-
0028157438
-
Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia
-
Denke M.A., Grundy S.M. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia. Arch Intern Med. 154:1994;317-325.
-
(1994)
Arch Intern Med
, vol.154
, pp. 317-325
-
-
Denke, M.A.1
Grundy, S.M.2
-
32
-
-
0029862973
-
Hyperinsulinemia as an independent risk factor for ischemic heart disease
-
Despres J.P., Lamarche B., Mauriege P.et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 334:1996;952-957.
-
(1996)
N Engl J Med
, vol.334
, pp. 952-957
-
-
Despres, J.P.1
Lamarche, B.2
Mauriege, P.3
-
33
-
-
0028196756
-
The insulin resistance syndrome (syndrome X) and risk factors for coronary heart disease. An epidemiologic overview
-
Donahue R.P. The insulin resistance syndrome (syndrome X) and risk factors for coronary heart disease. An epidemiologic overview. Endocrinologist. 4:1994;112-116.
-
(1994)
Endocrinologist
, vol.4
, pp. 112-116
-
-
Donahue, R.P.1
-
34
-
-
0026702131
-
Relation of level of high-density lipoprotein subfractions to the presence of extent of coronary artery disease
-
Drexel H., Amann F.W., Rentsch K.et al. Relation of level of high-density lipoprotein subfractions to the presence of extent of coronary artery disease. Am J Cardiol. 70:1992;436-440.
-
(1992)
Am J Cardiol
, vol.70
, pp. 436-440
-
-
Drexel, H.1
Amann, F.W.2
Rentsch, K.3
-
35
-
-
0344499774
-
Hypertriglyceridemia. Pathophysiology, diagnosis, and treatment
-
Duell P.B. Hypertriglyceridemia. Pathophysiology, diagnosis, and treatment. Endocrinologist. 2:1992;321-331.
-
(1992)
Endocrinologist
, vol.2
, pp. 321-331
-
-
Duell, P.B.1
-
36
-
-
0024500560
-
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases
-
Eckel R.H. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med. 320:1989;1060-1068.
-
(1989)
N Engl J Med
, vol.320
, pp. 1060-1068
-
-
Eckel, R.H.1
-
37
-
-
0023930868
-
Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
-
The Expert Panel of the National Cholesterol Education Program
-
The Expert Panel of the National Cholesterol Education Program: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148:36-69, 1988.
-
(1988)
Arch Intern Med
, vol.148
, pp. 36-69
-
-
-
38
-
-
0027243348
-
Summary of the second report on the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
-
The Expert Panel on Detection, Evaluation, and Treatment of High Blood cholesterol in Adults
-
The Expert Panel on Detection, Evaluation, and Treatment of High Blood cholesterol in Adults: Summary of the second report on the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993.
-
(1993)
JAMA
, vol.269
, pp. 3015-3023
-
-
-
39
-
-
0025780331
-
Hyperinsulinemia. The key feature of a cardiovascular and metabolic syndrome
-
Ferrannini E., Haffner S.M., Mitchell B.D., Stern M.P. Hyperinsulinemia. The key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34:1991;416-422.
-
(1991)
Diabetologia
, vol.34
, pp. 416-422
-
-
Ferrannini, E.1
Haffner, S.M.2
Mitchell, B.D.3
Stern, M.P.4
-
40
-
-
0025907493
-
Antihypertensive agents, serum lipoproteins, and glucose metabolism
-
Ferrari P., Rosman J., Weidmann P. Antihypertensive agents, serum lipoproteins, and glucose metabolism. Am J Cardiol. 67:1991;26B-35B.
-
(1991)
Am J Cardiol
, vol.67
-
-
Ferrari, P.1
Rosman, J.2
Weidmann, P.3
-
41
-
-
0027525254
-
Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level
-
Freedman S.F., Freedman N.J., Shields M.B.et al. Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. Am J Ophthalmol. 116:1993;600-611.
-
(1993)
Am J Ophthalmol
, vol.116
, pp. 600-611
-
-
Freedman, S.F.1
Freedman, N.J.2
Shields, M.B.3
-
42
-
-
0023232216
-
Helsinki Heart Study. Primary prevention trial of gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
-
Frick M.H., Elo O., Haapa K.et al. Helsinki Heart Study. Primary prevention trial of gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 317:1987;1237-1245.
-
(1987)
N Engl J Med
, vol.317
, pp. 1237-1245
-
-
Frick, M.H.1
Elo, O.2
Haapa, K.3
-
43
-
-
0028134712
-
Topical ophthalmic β-adrenergic blockade for the treatment of glaucoma and ocular hypertension
-
Frishman W.H., Fuksbrumer M.S., Tannenbaum M. Topical ophthalmic β-adrenergic blockade for the treatment of glaucoma and ocular hypertension. J Clin Pharmacol. 34:1994;795-803.
-
(1994)
J Clin Pharmacol
, vol.34
, pp. 795-803
-
-
Frishman, W.H.1
Fuksbrumer, M.S.2
Tannenbaum, M.3
-
44
-
-
0030049396
-
Cholesterol screening in asymptomatic adults, revisited, part 2
-
Garber A.M., Browner W.S., Hulley S.B. Cholesterol screening in asymptomatic adults, revisited, part 2. Ann Intern Med. 124:1996;518-531.
-
(1996)
Ann Intern Med
, vol.124
, pp. 518-531
-
-
Garber, A.M.1
Browner, W.S.2
Hulley, S.B.3
-
45
-
-
0028126081
-
Lipoprotein metabolism and its relationship to atherosclerosis
-
Ginsberg H.N. Lipoprotein metabolism and its relationship to atherosclerosis. Med Clin North Am. 78:1994;1-20.
-
(1994)
Med Clin North Am
, vol.78
, pp. 1-20
-
-
Ginsberg, H.N.1
-
46
-
-
0015839023
-
Hyperlipidemia and coronary artery disease. I. Lipid levels in 500 survivors of myocardial infarction
-
Goldstein J.L., Hazzard W.R., Schrott H.et al. Hyperlipidemia and coronary artery disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 52:1973;1533-1543.
-
(1973)
J Clin Invest
, vol.52
, pp. 1533-1543
-
-
Goldstein, J.L.1
Hazzard, W.R.2
Schrott, H.3
-
47
-
-
0015796295
-
Hyperlipidemia in coronary artery disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
-
Goldstein J.L., Schrott H., Hazzard W.R.et al. Hyperlipidemia in coronary artery disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 52:1973;1544-1568.
-
(1973)
J Clin Invest
, vol.52
, pp. 1544-1568
-
-
Goldstein, J.L.1
Schrott, H.2
Hazzard, W.R.3
-
48
-
-
0024449985
-
High-density lipoprotein. The clinical implications of recent studies
-
Gordon D.J., Rifkind B.M. High-density lipoprotein. The clinical implications of recent studies. N Engl J Med. 321:1989;1311-1316.
-
(1989)
N Engl J Med
, vol.321
, pp. 1311-1316
-
-
Gordon, D.J.1
Rifkind, B.M.2
-
49
-
-
0026344120
-
Heterogenous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency
-
Gotoda T., Yamada N., Kawamura M.et al. Heterogenous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J Clin Invest. 88:1991;1856-1864.
-
(1991)
J Clin Invest
, vol.88
, pp. 1856-1864
-
-
Gotoda, T.1
Yamada, N.2
Kawamura, M.3
-
51
-
-
0026062564
-
Workshop II - Hypertension trials and meta-analyses. Is there any value for further studies?
-
Grimm R.H., Black H. Workshop II - hypertension trials and meta-analyses. Is there any value for further studies? Am J Med. 90(Suppl 2A):1991;S24-S25.
-
(1991)
Am J Med
, vol.90
, Issue.SUPPL. 2A
-
-
Grimm, R.H.1
Black, H.2
-
52
-
-
0026586191
-
Two different views of the relationship of hypertriglyceridemia to coronary heart disease
-
Grundy S.M., Vega G.L. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Arch Intern Med. 152:1992;28-34.
-
(1992)
Arch Intern Med
, vol.152
, pp. 28-34
-
-
Grundy, S.M.1
Vega, G.L.2
-
53
-
-
0028569584
-
Choosing the right β-blocker. A guide to selection
-
Hampton J.R. Choosing the right β-blocker. A guide to selection. Drugs. 48:1994;549-568.
-
(1994)
Drugs
, vol.48
, pp. 549-568
-
-
Hampton, J.R.1
-
54
-
-
0027489806
-
The place of β-blockers in the treatment of hypertension in 1993
-
Hansson L. The place of β-blockers in the treatment of hypertension in 1993. Clin Exp Hyperten. 15:1993;1257-1262.
-
(1993)
Clin Exp Hyperten
, vol.15
, pp. 1257-1262
-
-
Hansson, L.1
-
55
-
-
0027359490
-
How well are the cardiovascular risk profiles modulated by current beta blockers in hypertension?
-
Hayduk K. How well are the cardiovascular risk profiles modulated by current beta blockers in hypertension? Cardiology. 82(Suppl 3):1993;3-7.
-
(1993)
Cardiology
, vol.82
, Issue.SUPPL. 3
, pp. 3-7
-
-
Hayduk, K.1
-
56
-
-
0015892771
-
Hyperlipidemia in coronary artery disease
-
Hazzard W.R., Goldstein J.L., Schrott H.et al. Hyperlipidemia in coronary artery disease. III. Evaluation of lipoprotein phenotypes of. 156(genetically defined survivors of myocardial infarction. J Clin Invest 52):1973;1569-1577.
-
(1973)
III. Evaluation of Lipoprotein Phenotypes of
, vol.156
, Issue.GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION. J CLIN INVEST 52
, pp. 1569-1577
-
-
Hazzard, W.R.1
Goldstein, J.L.2
Schrott, H.3
-
57
-
-
0026683060
-
Saturated fats, cholesterol and dietary compliance
-
Henkin Y., Garber D.W., Osterlund L.D., Darnell B.E. Saturated fats, cholesterol and dietary compliance. Arch Intern Med. 152:1992;1167-1174.
-
(1992)
Arch Intern Med
, vol.152
, pp. 1167-1174
-
-
Henkin, Y.1
Garber, D.W.2
Osterlund, L.D.3
Darnell, B.E.4
-
58
-
-
0025102741
-
Familial defective apolipoprotein B-100: A mutation of apolipoprotein B that causes hypercholesterolemia
-
Innerarity T.L., Mahley R.W., Weisgraber K.H.et al. Familial defective apolipoprotein B-100. a mutation of apolipoprotein B that causes hypercholesterolemia J Lipid Res. 31:1990;1337-1349.
-
(1990)
J Lipid Res
, vol.31
, pp. 1337-1349
-
-
Innerarity, T.L.1
Mahley, R.W.2
Weisgraber, K.H.3
-
59
-
-
0030066167
-
Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms
-
Innerarity T.L., Boren J., Yamanaka S., Olofsson S.-O. Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. J Biol Chem. 271:1996;2353-2356.
-
(1996)
J Biol Chem
, vol.271
, pp. 2353-2356
-
-
Innerarity, T.L.1
Boren, J.2
Yamanaka, S.3
Olofsson, S.-O.4
-
60
-
-
0028032971
-
Efficacy and safety of once-daily vs. twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia
-
Insull W. Jr., Black D., Dujovne C.et al. Efficacy and safety of once-daily vs. twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia. Arch Intern Med. 154:1994;2449-2455.
-
(1994)
Arch Intern Med
, vol.154
, pp. 2449-2455
-
-
Insull W., Jr.1
Black, D.2
Dujovne, C.3
-
61
-
-
0028067987
-
The ACE inhibitor alacepril suppresses atherogenesis independent of serum lipids in cholesterol-fed rabbits. Critical analysis with new ultrasound technique
-
Itoh K., Yoshida S., Fukuda M. The ACE inhibitor alacepril suppresses atherogenesis independent of serum lipids in cholesterol-fed rabbits. Critical analysis with new ultrasound technique. Jpn Circ J. 58:1994;844-854.
-
(1994)
Jpn Circ J
, vol.58
, pp. 844-854
-
-
Itoh, K.1
Yoshida, S.2
Fukuda, M.3
-
62
-
-
1842404801
-
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
-
for the Scandinavian Simvastatin Survival Study
-
Johannesson M., Jonsson B., Kjekshus J.et al., for the Scandinavian Simvastatin Survival Study Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med. 336:1997;332-336.
-
(1997)
N Engl J Med
, vol.336
, pp. 332-336
-
-
Johannesson, M.1
Jonsson, B.2
Kjekshus, J.3
-
63
-
-
0020062176
-
The emerging problem of plasma lipid changes during antihypertensive therapy
-
Johnson B.F. The emerging problem of plasma lipid changes during antihypertensive therapy. J Cardiovasc Pharmacol. 4(Suppl 2):1982;S213-S221.
-
(1982)
J Cardiovasc Pharmacol
, vol.4
, Issue.SUPPL. 2
-
-
Johnson, B.F.1
-
64
-
-
0025900794
-
Lecithin-cholesterol acyltransferase in metabolism of high-density lipoproteins
-
Jonas A. Lecithin-cholesterol acyltransferase in metabolism of high-density lipoproteins. Biochim Biophys Acta. 1084:1991;205-220.
-
(1991)
Biochim Biophys Acta
, vol.1084
, pp. 205-220
-
-
Jonas, A.1
-
65
-
-
0025685469
-
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
-
Kane J.P., Malloy M.J., Ports T.A.et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA. 264:1990;3007-3012.
-
(1990)
JAMA
, vol.264
, pp. 3007-3012
-
-
Kane, J.P.1
Malloy, M.J.2
Ports, T.A.3
-
66
-
-
0018412417
-
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study
-
Kannel W.B., Castelli W.P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study. Ann Intern Med. 90:1979;85-91.
-
(1979)
Ann Intern Med
, vol.90
, pp. 85-91
-
-
Kannel, W.B.1
Castelli, W.P.2
Gordon, T.3
-
67
-
-
0027310351
-
Multicenter double-blind comparison of carteolol and timolol in primary open-angle glaucoma and ocular hypertension
-
Kitazawa Y. Multicenter double-blind comparison of carteolol and timolol in primary open-angle glaucoma and ocular hypertension. Adv Ther. 10:1993;95-131.
-
(1993)
Adv Ther
, vol.10
, pp. 95-131
-
-
Kitazawa, Y.1
-
68
-
-
0030278155
-
Cholesterol-lowering and coronary atherosclerosis. Good news and bad news
-
Kreisberg R.A. Cholesterol-lowering and coronary atherosclerosis. Good news and bad news. Am J Med. 101:1996;455-458.
-
(1996)
Am J Med
, vol.101
, pp. 455-458
-
-
Kreisberg, R.A.1
-
69
-
-
0027396927
-
Low high-density lipoprotein cholesterol. What does it mean, what can we do about it, and what should we do about it?
-
Kreisberg R.A. Low high-density lipoprotein cholesterol. What does it mean, what can we do about it, and what should we do about it? Am J Med. 94:1993;1-6.
-
(1993)
Am J Med
, vol.94
, pp. 1-6
-
-
Kreisberg, R.A.1
-
70
-
-
0028866519
-
Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction
-
Lacoste L., Lam J.Y.T., Hung J.et al. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation. 92:1995;3172-3177.
-
(1995)
Circulation
, vol.92
, pp. 3172-3177
-
-
Lacoste, L.1
Lam, J.Y.T.2
Hung, J.3
-
71
-
-
0030027548
-
Cholesterol agonistics
-
LaRosa J.C. Cholesterol agonistics. Ann Intern Med. 124:1996;505-508.
-
(1996)
Ann Intern Med
, vol.124
, pp. 505-508
-
-
Larosa, J.C.1
-
72
-
-
0022569218
-
A new challenge for America. The National Cholesterol Education Program
-
Lenfant C. A new challenge for America. The National Cholesterol Education Program. Circulation. 73:1986;855-856.
-
(1986)
Circulation
, vol.73
, pp. 855-856
-
-
Lenfant, C.1
-
73
-
-
0021288690
-
Effect of alpha- And beta-blocker therapy on blood lipids. European experience
-
Leren P. Effect of alpha- and beta-blocker therapy on blood lipids. European experience. Am J Med. 75:1984;67-71.
-
(1984)
Am J Med
, vol.75
, pp. 67-71
-
-
Leren, P.1
-
74
-
-
0027430962
-
Ischaemic heart disease. How well are the risk profiles modulated by current beta blockers?
-
Leren P. Ischaemic heart disease. How well are the risk profiles modulated by current beta blockers? Cardiology. 82(Suppl 3):1993;8-12.
-
(1993)
Cardiology
, vol.82
, Issue.SUPPL. 3
, pp. 8-12
-
-
Leren, P.1
-
75
-
-
0029650740
-
Cholesterol reduction and cardiovascular disease. Clinical benefits and possible mechanisms
-
Levine G.N., Keaney J.F. Jr., Vita J.A. Cholesterol reduction and cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med. 332:1995;512-521.
-
(1995)
N Engl J Med
, vol.332
, pp. 512-521
-
-
Levine, G.N.1
Keaney J.F., Jr.2
Vita, J.A.3
-
76
-
-
0019080054
-
The structure, function and metabolism of high-density lipoproteins. A status report
-
Levy R.I., Rifkind B.M. The structure, function and metabolism of high-density lipoproteins. A status report. Circulation. 62(Suppl IV):1980;4-8.
-
(1980)
Circulation
, vol.62
, Issue.SUPPL. IV
, pp. 4-8
-
-
Levy, R.I.1
Rifkind, B.M.2
-
77
-
-
0027974105
-
Long-term metabolic effects of antihypertensive drugs
-
Lind L., Pollare T., Berne C., Lithell H. Long-term metabolic effects of antihypertensive drugs. Am Heart J. 128:1994;1177-1183.
-
(1994)
Am Heart J
, vol.128
, pp. 1177-1183
-
-
Lind, L.1
Pollare, T.2
Berne, C.3
Lithell, H.4
-
78
-
-
0025870053
-
Angiographic evolution of coronary atherosclerosis in patients receiving propranolol
-
Loaldi A., Montorsi P., Fabbiocchi F.et al. Angiographic evolution of coronary atherosclerosis in patients receiving propranolol. Chest. 99:1991;1238-1242.
-
(1991)
Chest
, vol.99
, pp. 1238-1242
-
-
Loaldi, A.1
Montorsi, P.2
Fabbiocchi, F.3
-
79
-
-
0025966833
-
Effects of adrenaline and noradrenaline on clearance of triacylglycerol-rich lipoproteins from plasma: Studies with chylomicron-like lipid emulsions in rats
-
Mackintosh V., Redgrave T. Effects of adrenaline and noradrenaline on clearance of triacylglycerol-rich lipoproteins from plasma. studies with chylomicron-like lipid emulsions in rats Clin Exp Pharmacol Physiol. 18:1991;137-143.
-
(1991)
Clin Exp Pharmacol Physiol
, vol.18
, pp. 137-143
-
-
Mackintosh, V.1
Redgrave, T.2
-
80
-
-
0023726344
-
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
-
Mannienen V., Elo O., Frick M.H.et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 260:1988;641-651.
-
(1988)
JAMA
, vol.260
, pp. 641-651
-
-
Mannienen, V.1
Elo, O.2
Frick, M.H.3
-
81
-
-
0030176054
-
Inadequate treatment with HMG-CoA reductase inhibitors by health care providers
-
Marcelino J.J., Feingold K.R. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers. Am J Med. 100:1996;605-610.
-
(1996)
Am J Med
, vol.100
, pp. 605-610
-
-
Marcelino, J.J.1
Feingold, K.R.2
-
82
-
-
0022980592
-
Serum cholesterol, blood pressure, and mortality
-
Martin M.J., Hulley S.B., Browner W.S.et al. Serum cholesterol, blood pressure, and mortality. Implications from a cohort of. 361,662(men. Lancet 2):1986;933-936.
-
(1986)
Implications from a Cohort of
, vol.361-662
, Issue.MEN. LANCET 2
, pp. 933-936
-
-
Martin, M.J.1
Hulley, S.B.2
Browner, W.S.3
-
83
-
-
0021863832
-
MRC trial of treatment of mild hypertension: Principal results
-
Medical Research Council Working Party MRC trial of treatment of mild hypertension. principal results BMJ. 291:1985;97-104.
-
(1985)
BMJ
, vol.291
, pp. 97-104
-
-
Medical Research Council Working Party1
-
84
-
-
0026669282
-
Long-term predictors of subsequent cardiovascular events with coronary artery disease and "desirable" levels of plasma total cholesterol
-
Miller M., Seidler A., Kwiterovich P.O., Pearson T.A. Long-term predictors of subsequent cardiovascular events with coronary artery disease and "desirable" levels of plasma total cholesterol. Circulation. 86:1992;1165-1170.
-
(1992)
Circulation
, vol.86
, pp. 1165-1170
-
-
Miller, M.1
Seidler, A.2
Kwiterovich, P.O.3
Pearson, T.A.4
-
85
-
-
0029152834
-
New methods for rapid detection of low-density lipoprotein receptor and apolipoprotein B gene mutations causing familial hypercholesterolemia
-
Minnich A., Roy M., Chamberland A.et al. New methods for rapid detection of low-density lipoprotein receptor and apolipoprotein B gene mutations causing familial hypercholesterolemia. Clin Biochem. 28:1995;277-284.
-
(1995)
Clin Biochem
, vol.28
, pp. 277-284
-
-
Minnich, A.1
Roy, M.2
Chamberland, A.3
-
86
-
-
0018718026
-
A longitudinal study of the biological variability of plasma lipoproteins in healthy young adults
-
Mjøs O.D., Rao S.N., Bjøru L.et al. A longitudinal study of the biological variability of plasma lipoproteins in healthy young adults. Atherosclerosis. 34:1979;75-81.
-
(1979)
Atherosclerosis
, vol.34
, pp. 75-81
-
-
Mjøs, O.D.1
Rao, S.N.2
Bjøru, L.3
-
87
-
-
0026681128
-
Serum cholesterol and mortality findings for men screened in the Multiple Risk Factor Intervention Trial
-
Neaton J.D., Blackburn H., Jacobs D.et al. Serum cholesterol and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med. 152:1992;1490-1500.
-
(1992)
Arch Intern Med
, vol.152
, pp. 1490-1500
-
-
Neaton, J.D.1
Blackburn, H.2
Jacobs, D.3
-
88
-
-
0026593243
-
Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men
-
for the Multiple Risk Factor Intervention Trial Research Group
-
Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med 152:56-64, 1992.
-
(1992)
Arch Intern Med
, vol.152
, pp. 56-64
-
-
Neaton, J.D.1
Wentworth, D.2
-
89
-
-
0027175545
-
Calcium channel blockers in the management of low-tension and open-angle glaucoma
-
Netland P.A., Chaturvedi N., Dreyer E.B. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 115:1993;608-613.
-
(1993)
Am J Ophthalmol
, vol.115
, pp. 608-613
-
-
Netland, P.A.1
Chaturvedi, N.2
Dreyer, E.B.3
-
90
-
-
0002533264
-
Receptor mechanisms for epinephrine and timolol
-
E. Lutjen-Drecoll. Stuttgart: Germany, Schattauer
-
Neufeld A.H., Bartels S.P. Receptor mechanisms for epinephrine and timolol. Lutjen-Drecoll E. Basic Aspects of Glaucoma Research. 1982;113-122 Germany, Schattauer, Stuttgart.
-
(1982)
Basic Aspects of Glaucoma Research
, pp. 113-122
-
-
Neufeld, A.H.1
Bartels, S.P.2
-
91
-
-
0026573169
-
Serum cholesterol profiles during treatment of obese outpatients with a very low calorie diet. Effect of initial cholesterol levels
-
Osterman J., Lin T., Nankin H.R.et al. Serum cholesterol profiles during treatment of obese outpatients with a very low calorie diet. Effect of initial cholesterol levels. Int J Obesity. 16:1992;49-58.
-
(1992)
Int J Obesity
, vol.16
, pp. 49-58
-
-
Osterman, J.1
Lin, T.2
Nankin, H.R.3
-
92
-
-
0030932585
-
Nonlipoprotein risk factors for coronary heart disease. Evaluation and management
-
Parmley W.W. Nonlipoprotein risk factors for coronary heart disease. Evaluation and management. Am J Med. 102(Suppl 2A):1997;7-14.
-
(1997)
Am J Med
, vol.102
, Issue.SUPPL. 2A
, pp. 7-14
-
-
Parmley, W.W.1
-
94
-
-
10244249180
-
Safety and tolerability of cholesterol lowering with simvastatin during five years in the Scandinavian Simvastatin Survival Study
-
Pedersen T.R., Berg K., Cook T.J.et al. Safety and tolerability of cholesterol lowering with simvastatin during five years in the Scandinavian Simvastatin Survival Study. Arch Intern Med. 156:1996;2085-2092.
-
(1996)
Arch Intern Med
, vol.156
, pp. 2085-2092
-
-
Pedersen, T.R.1
Berg, K.2
Cook, T.J.3
-
95
-
-
0029883280
-
Cholesterol lowering and the use of health care resources. Results of the Scandinavian Simvastatin Survival Study
-
Pedersen T.R., Kjekshus J., Berg K.et al. Cholesterol lowering and the use of health care resources. Results of the Scandinavian Simvastatin Survival Study. Circulation. 93:1996;1796-1802.
-
(1996)
Circulation
, vol.93
, pp. 1796-1802
-
-
Pedersen, T.R.1
Kjekshus, J.2
Berg, K.3
-
96
-
-
0028069487
-
In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport
-
Pieters M.N., Schouten D., Van Berkel T.J.C. In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim Biophys Acta. 1225:1994;125-134.
-
(1994)
Biochim Biophys Acta
, vol.1225
, pp. 125-134
-
-
Pieters, M.N.1
Schouten, D.2
Van Berkel, T.J.C.3
-
97
-
-
0027731239
-
Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs
-
Rajman I., Kendall M.J. Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs. Postgrad Med J. 69:1993;903-911.
-
(1993)
Postgrad Med J
, vol.69
, pp. 903-911
-
-
Rajman, I.1
Kendall, M.J.2
-
98
-
-
0027183606
-
Insulin resistance and hyperinsulinemia in individuals with small, dense low-density lipoprotein particles
-
Reaven G.M., Chen Y.D.I., Jeppesen J.et al. Insulin resistance and hyperinsulinemia in individuals with small, dense low-density lipoprotein particles. J Clin Invest. 92:1993;141-146.
-
(1993)
J Clin Invest
, vol.92
, pp. 141-146
-
-
Reaven, G.M.1
Chen, Y.D.I.2
Jeppesen, J.3
-
99
-
-
0029946120
-
Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit?
-
Reaven G.M., Chen Y.D.I. Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit? Circulation. 93:1996;1780-1783.
-
(1996)
Circulation
, vol.93
, pp. 1780-1783
-
-
Reaven, G.M.1
Chen, Y.D.I.2
-
100
-
-
0024388998
-
Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism
-
Reichl D., Miller N.E. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis. 9:1989;785-797.
-
(1989)
Arteriosclerosis
, vol.9
, pp. 785-797
-
-
Reichl, D.1
Miller, N.E.2
-
101
-
-
0028265434
-
The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels
-
Roberts W.C. The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels. Am J Cardiol. 73:1994;623-624.
-
(1994)
Am J Cardiol
, vol.73
, pp. 623-624
-
-
Roberts, W.C.1
-
102
-
-
0027733783
-
Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs
-
Robles R.G., Villa E., Santirso R.et al. Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs. Am J Hypertens. 6:1993;1009-1015.
-
(1993)
Am J Hypertens
, vol.6
, pp. 1009-1015
-
-
Robles, R.G.1
Villa, E.2
Santirso, R.3
-
103
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
-
Sacks F.M., Pfeffer M.A., Moye L.A.et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 335:1996;1001-1009.
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
-
104
-
-
0026657142
-
Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Imai rats
-
Sakemi T., Baba N., Yoshikawa Y. Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Imai rats. Nephron. 62:1992;315-321.
-
(1992)
Nephron
, vol.62
, pp. 315-321
-
-
Sakemi, T.1
Baba, N.2
Yoshikawa, Y.3
-
105
-
-
0025974363
-
The familial hyperchylomicronemia syndrome. New insights into underlying genetic defects
-
Santamarina-Fojo S., Brewer H.B. Jr. The familial hyperchylomicronemia syndrome. New insights into underlying genetic defects. JAMA. 265:1991;904-908.
-
(1991)
JAMA
, vol.265
, pp. 904-908
-
-
Santamarina-Fojo, S.1
Brewer H.B., Jr.2
-
106
-
-
0027987849
-
Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S)
-
The Scandinavian Simvastatin Survival Group Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (. 4S).(Lancet 344):1994;1383-1389.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
The Scandinavian Simvastatin Survival Group1
-
107
-
-
0028316960
-
Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial
-
Schaefer E.J., Lamon-Fava S., Jenner J.L.et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial. JAMA. 271:1994;999-1003.
-
(1994)
JAMA
, vol.271
, pp. 999-1003
-
-
Schaefer, E.J.1
Lamon-Fava, S.2
Jenner, J.L.3
-
108
-
-
0028828560
-
Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet
-
Schaefer E.J., Lichtenstein A.H., Lamon-Fava S.et al. Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA. 274:1995;1450-1455.
-
(1995)
JAMA
, vol.274
, pp. 1450-1455
-
-
Schaefer, E.J.1
Lichtenstein, A.H.2
Lamon-Fava, S.3
-
109
-
-
0028011096
-
Familial lipoprotein disorders and premature coronary artery disease
-
Schaefer E.J. Familial lipoprotein disorders and premature coronary artery disease. Med Clin North Am. 78:1994;21-39.
-
(1994)
Med Clin North Am
, vol.78
, pp. 21-39
-
-
Schaefer, E.J.1
-
110
-
-
0027724204
-
Metabolic effects of converting enzyme inhibitors. Focus on the reduction of cholesterol and lipoprotein(a) by fosinopril
-
Schlueter W., Keilani T., Batlle D.C. Metabolic effects of converting enzyme inhibitors. Focus on the reduction of cholesterol and lipoprotein(a) by fosinopril. Am J Cardiol. 72:1993;37H-44H.
-
(1993)
Am J Cardiol
, vol.72
-
-
Schlueter, W.1
Keilani, T.2
Batlle, D.C.3
-
111
-
-
0019945144
-
Central role of high density lipoprotein in plasma free cholesterol metabolism
-
Schwartz C.C., Vlahcevic Z.R., Berman M.et al. Central role of high density lipoprotein in plasma free cholesterol metabolism. J Clin Invest. 70:1982;105-116.
-
(1982)
J Clin Invest
, vol.70
, pp. 105-116
-
-
Schwartz, C.C.1
Vlahcevic, Z.R.2
Berman, M.3
-
112
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
-
Shepherd J., Cobbe S.M., Ford J.et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 333:1995;1301-1307.
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, J.3
-
115
-
-
0027164257
-
Comparison of the efficacy, safety, and tolerability of simvastatin and pravastatin for hypercholesterolemia
-
The Simvastatin Pravastatin Study Group Comparison of the efficacy, safety, and tolerability of simvastatin and pravastatin for hypercholesterolemia. Am J Cardiol. 71:1993;1408-1414.
-
(1993)
Am J Cardiol
, vol.71
, pp. 1408-1414
-
-
The Simvastatin Pravastatin Study Group1
-
116
-
-
0019454574
-
Beta-adrenergic blockade after myocardial infarction
-
Sleight P. Beta-adrenergic blockade after myocardial infarction. N Engl J Med. 304:1981;837-838.
-
(1981)
N Engl J Med
, vol.304
, pp. 837-838
-
-
Sleight, P.1
-
117
-
-
0001434733
-
Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
-
for the MRFIT Research Group
-
Stamler J, Wentworth D, Neaton J, for the MRFIT Research Group: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 269:3015-3023, 1993.
-
(1993)
JAMA
, vol.269
, pp. 3015-3023
-
-
Stamler, J.1
Wentworth, D.2
Neaton, J.3
-
118
-
-
0029741921
-
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
-
Stampfer M.J., Krauss R.M., Ma J.et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 276:1996;882-888.
-
(1996)
JAMA
, vol.276
, pp. 882-888
-
-
Stampfer, M.J.1
Krauss, R.M.2
Ma, J.3
-
119
-
-
0028348823
-
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low-density lipoprotein cholesterol
-
Stewart B.F., Brown B.G., Zhae X.-Q.et al. Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low-density lipoprotein cholesterol. J Am Coll Cardiol. 23:1994;899-906.
-
(1994)
J Am Coll Cardiol
, vol.23
, pp. 899-906
-
-
Stewart, B.F.1
Brown, B.G.2
Zhae, X.-Q.3
-
120
-
-
0004124919
-
-
Thorofare, NJ, Slack, Inc.
-
Stewart WC: Clinical Practice of Glaucoma. Thorofare, NJ, Slack, Inc., 1990, pp 149-163.
-
(1990)
Clinical Practice of Glaucoma
, pp. 149-163
-
-
Stewart, W.C.1
-
121
-
-
0012615809
-
Prostaglandin analogues: Their usage and benefits in glaucoma treatment
-
Stewart W.C. Prostaglandin analogues. their usage and benefits in glaucoma treatment Ophthalmic Pract. 14:1996;48-55.
-
(1996)
Ophthalmic Pract
, vol.14
, pp. 48-55
-
-
Stewart, W.C.1
-
122
-
-
0027179580
-
Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease
-
Superko H.R., Haskell W.L., Krauss R.M. Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease. Atherosclerosis. 101:1993;1-8.
-
(1993)
Atherosclerosis
, vol.101
, pp. 1-8
-
-
Superko, H.R.1
Haskell, W.L.2
Krauss, R.M.3
-
123
-
-
0024996141
-
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis
-
Tall A.R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest. 86:1990;379-384.
-
(1990)
J Clin Invest
, vol.86
, pp. 379-384
-
-
Tall, A.R.1
-
124
-
-
0027942931
-
The triglyceride issue revisited. Findings from the Helsinki Heart Study
-
Tenkanen L., Pietila K., Mannienen V., Manttari M. The triglyceride issue revisited. Findings from the Helsinki Heart Study. Arch Intern Med. 154:1994;2714-2720.
-
(1994)
Arch Intern Med
, vol.154
, pp. 2714-2720
-
-
Tenkanen, L.1
Pietila, K.2
Mannienen, V.3
Manttari, M.4
-
125
-
-
0029103672
-
Familial hypercholesterolemia regression study. A randomized trial of low-density lipoprotein apheresis
-
Thompson G.R., Maher V.M.G., Mathews S.et al. Familial hypercholesterolemia regression study. A randomized trial of low-density lipoprotein apheresis. Lancet. 345:1995;811-816.
-
(1995)
Lancet
, vol.345
, pp. 811-816
-
-
Thompson, G.R.1
Maher, V.M.G.2
Mathews, S.3
-
126
-
-
0020624054
-
Conflicting clinical trials and the uncertainty of treating mild hypertension
-
Toth P.J., Horwitz R.I. Conflicting clinical trials and the uncertainty of treating mild hypertension. Am J Med. 75:1983;482-488.
-
(1983)
Am J Med
, vol.75
, pp. 482-488
-
-
Toth, P.J.1
Horwitz, R.I.2
-
127
-
-
0028910272
-
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
-
Treasure C.B., Klein J.L., Weintraub W.S.et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 332:1995;481-487.
-
(1995)
N Engl J Med
, vol.332
, pp. 481-487
-
-
Treasure, C.B.1
Klein, J.L.2
Weintraub, W.S.3
-
128
-
-
84942480790
-
L(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men
-
Valentine J.R., Grayburn P.A., Vega G.L., Grundy S.M. L(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med. 154:1994;801-806.
-
(1994)
Arch Intern Med
, vol.154
, pp. 801-806
-
-
Valentine, J.R.1
Grayburn, P.A.2
Vega, G.L.3
Grundy, S.M.4
-
129
-
-
0020534844
-
The relevance of intrinsic sympathomimetic activity for β-blocker-induced changes in plasma lipids
-
van Brummelen P. The relevance of intrinsic sympathomimetic activity for β-blocker-induced changes in plasma lipids. J Cardiovasc Pharmacol. 5:1983;S51-S55.
-
(1983)
J Cardiovasc Pharmacol
, vol.5
-
-
Van Brummelen, P.1
-
130
-
-
0000306390
-
Statins do more than just lower cholesterol
-
Vaughan C.J., Murphy M.B., Buckley B.M. Statins do more than just lower cholesterol. Lancet. 348:1996;1079-1082.
-
(1996)
Lancet
, vol.348
, pp. 1079-1082
-
-
Vaughan, C.J.1
Murphy, M.B.2
Buckley, B.M.3
-
131
-
-
0029060065
-
Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Country Study
-
Verschuren W.M.M., Jacobs D.R., Bloemberg B.P.M.et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Country Study. JAMA. 274:1995;131-136.
-
(1995)
JAMA
, vol.274
, pp. 131-136
-
-
Verschuren, W.M.M.1
Jacobs, D.R.2
Bloemberg, B.P.M.3
-
132
-
-
2642659615
-
Effects of antihypertensive therapy on serum lipoproteins
-
Weidmann P, Gerber A, Mordasini R: Effects of antihypertensive therapy on serum lipoproteins. Hypertension 5:III120-131, 1983.
-
(1983)
Hypertension
, vol.5
-
-
Weidmann, P.1
Gerber, A.2
Mordasini, R.3
-
133
-
-
0025080789
-
Topical timolol and serum lipoproteins
-
West J., Longstaff S. Topical timolol and serum lipoproteins. Br J Ophthalmol. 74:1990;663-664.
-
(1990)
Br J Ophthalmol
, vol.74
, pp. 663-664
-
-
West, J.1
Longstaff, S.2
-
134
-
-
0027449252
-
Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in Utah
-
Williams R.R., Schumacher C., Barlow G.K.et al. Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in Utah. Am J Cardiol. 72:1993;18D-24D.
-
(1993)
Am J Cardiol
, vol.72
-
-
Williams, R.R.1
Schumacher, C.2
Barlow, G.K.3
-
135
-
-
0029300214
-
Pharmacologic therapy of angina pectoris
-
Zavecz J.H., Bueno O. Pharmacologic therapy of angina pectoris. J La State Med Soc. 147:1995;208-216.
-
(1995)
J la State Med Soc
, vol.147
, pp. 208-216
-
-
Zavecz, J.H.1
Bueno, O.2
|